Rothschild-Investment

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-08
Total Holdings
3,026
Total Value
1494573297
Accession Number
0001104659-25-032914
Form Type
13F-HR
Manager Name
Rothschild-Investment
Data Enrichment
88% identified
2,649 identified377 unidentified

Holdings

3,026 positions • $1.5B total value
Manager:
Search and click to pin securities to the top
TrueBlue, Inc.
Shares:20
Value:$106
% of Portfolio:0.0% ($106/$1.5B)
Under Armour, Inc.
Shares:17
Value:$106
% of Portfolio:0.0% ($106/$1.5B)
Booz Allen Hamilton Holding Corp
Shares:1
Value:$105
% of Portfolio:0.0% ($105/$1.5B)
Getty Images Holdings, Inc.
Shares:60
Value:$104
% of Portfolio:0.0% ($104/$1.5B)
ARROW ELECTRONICS, INC.
Shares:1
Value:$104
% of Portfolio:0.0% ($104/$1.5B)
QUICKLOGIC Corp
Shares:20
Value:$102
% of Portfolio:0.0% ($102/$1.5B)
DLH Holdings Corp.
Shares:25
Value:$101
% of Portfolio:0.0% ($101/$1.5B)
Voyager Therapeutics, Inc.
Shares:30
Value:$101
% of Portfolio:0.0% ($101/$1.5B)
Roivant Sciences Ltd.
Shares:10
Value:$101
% of Portfolio:0.0% ($101/$1.5B)
HOOKER FURNISHINGS Corp
Shares:10
Value:$100
% of Portfolio:0.0% ($100/$1.5B)
Certara, Inc.
Shares:10
Value:$99
% of Portfolio:0.0% ($99/$1.5B)
INOVIO PHARMACEUTICALS, INC.
Shares:60
Value:$98
% of Portfolio:0.0% ($98/$1.5B)
STRATASYS LTD.
Shares:10
Value:$98
% of Portfolio:0.0% ($98/$1.5B)
Cabaletta Bio, Inc.
Shares:70
Value:$97
% of Portfolio:0.0% ($97/$1.5B)
Terns Pharmaceuticals, Inc.
Shares:35
Value:$97
% of Portfolio:0.0% ($97/$1.5B)
Kyverna Therapeutics, Inc.
Shares:50
Value:$97
% of Portfolio:0.0% ($97/$1.5B)
OmniAb, Inc.
Shares:40
Value:$96
% of Portfolio:0.0% ($96/$1.5B)
AVIAT NETWORKS, INC.
Shares:5
Value:$96
% of Portfolio:0.0% ($96/$1.5B)
Sleep Number Corp
Shares:15
Value:$95
% of Portfolio:0.0% ($95/$1.5B)
3D SYSTEMS CORP
Shares:45
Value:$95
% of Portfolio:0.0% ($95/$1.5B)